CD8A and cervical squamous cell carcinoma: Flow cytometry analysis further validated these findings, revealing an increased percentage of HPV16-specific (tetramer+) CD8+ T cells from CESC patients compared to healthy donors after stimulation with MHC-I‒E7‒hEry (Fig. 2c).